Chronic Hepatitis B and Lymphoma
Links shared publicly online about this topic
Medical News: Chronic HBV Raises Lymphoma Risk - in Infectious Disease, Hepatitis from MedPage Today
medpagetoday.com — “Chronic hepatitis B virus infection -- common throughout Asia and Africa and often present since early in life -- raises the risk for non-Hodgkin's lymphoma, a large South Korean study confirmed.” View full resource at medpagetoday.com
Most Recently Shared on August 5, 2010 at 4:07 pm By:
Chronic HBV Raises Lymphoma Risk (CME/CE) (MedPage Today) -- Chronic hepatitis B virus infection -- common throughout A.. http://dld.bz/q8x4
Chronic HBV Raises Lymphoma Risk (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Chronic hepatitis B virus infection -- common throughout Asia and Africa and often present since early in life -- raises the risk for non-Hodgkin's lymphoma, a large South Korean study confirmed.” View full resource at qualitypointtech.net
Most Recently Shared on August 5, 2010 at 3:51 pm By:
Chronic HBV Raises Lymphoma Risk (CME/CE): (MedPage Today) -- Chronic hepatitis B virus infection -- common throug... http://bit.ly/91AY3e
Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study : The Lancet Oncology
thelancet.com — “Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. By - Eric A Engels MD, Eo Rin Cho PhD, Prof Sun Ha Jee PhD” View full resource at thelancet.com
Most Recently Shared on August 4, 2010 at 11:04 am By:
Are patients with HBV infection more likely to develop non-Hodgkin lymphoma? A South Korean study investigates. http://bit.ly/9xPgpM
Gastroenterology Article | Hepatitis B Lymphoma, B-Cell Hepatitis B Surface Antigens
mdlinx.com — “The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy” View full resource at mdlinx.com
Most Recently Shared on May 16, 2011 at 7:12 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diff... http://bit.ly/jVQVDw #GI
Oncology Article | Hepatitis B Lymphoma, B-Cell Hepatitis B Surface Antigens
mdlinx.com — “The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy” View full resource at mdlinx.com
Most Recently Shared on May 16, 2011 at 9:47 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients wit... http://bit.ly/iyVc9j #oncology
HBV Doubles Lymphoma Risk - QualityPoint Technologies
qualitypointtech.net — “Hepatitis B virus, like hepatitis C, is associated with a significant increase in risk for non-Hodgkin's lymphoma. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on August 11, 2010 at 3:36 pm By:
HBV Doubles Lymphoma Risk: Hepatitis B virus, like hepatitis C, is associated with a significant increase in risk ... http://bit.ly/9Y3aLV
Oncology News & Articles - MDLinx - Lymphoma Hepatitis B on #MDlinx
mdlinx.com — “Oncology News & Articles - MDLinx - Lymphoma Hepatitis B on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 5, 2010 at 9:15 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: A cohort study: The Lancet O... http://bit.ly/bZF0s2 #oncology
Hepatitis B Infection Patients Have Double The Risk Of Developing Non-Hodgkin Lymphoma
medicalnewstoday.com — “A study carried out in South Korea revealed that patients infected with hepatitis B (HBV) are around twice as likely to develop a common form of non-Hodgkin lymphoma (NHL). This is the conclusion” View full resource at medicalnewstoday.com
Most Recently Shared on August 4, 2010 at 2:06 pm By:
Hepatitis B Infection Patients Have Double The Risk Of Developing Non-Hodgkin Lymphoma http://mnt.to/3GWF #liver #hepatitis
Patients with hepatitis B infection twice as likely to develop non-Hodgkin lymphoma
physorg.com — “A South Korean study has shown that patients infected with hepatitis B (HBV) are around twice as likely to develop a common form of non-Hodgkin lymphoma (NHL). This is the conclusion of an Article published Online First in The Lancet Oncology, written by Dr Eric Engels, National Cancer Institute, Rockville, ...” View full resource at physorg.com
Most Recently Shared on August 3, 2010 at 10:30 pm By:
PhysOrg Health News Health News
Patients with hepatitis B infection twice as likely to develop non-Hodgkin lymphoma http://tw.physorg.com/200074639
Reactivation of hepatitis B virus following bendam... [Leuk Lymphoma. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on February 11, 2011 at 7:33 pm By:
Robert Z. Orlowski Physician, Doctor, and Internist
Chemotherapy with bendamustine for myeloma can activate hepatitis B (http://bit.ly/gp6f4u). Possible role for prophylaxis with lamivudine?
Gastroenterology Article | Hepatitis B, Chronic
mdlinx.com — “Update of chronic hepatitis B” View full resource at mdlinx.com
Most Recently Shared on May 6, 2011 at 4:48 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Update of chronic hepatitis B: Current Opinion in Gastroenterology http://bit.ly/lop7aE #GI
Gastroenterology Article | Hepatitis B, Chronic
mdlinx.com — “Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized open-label study” View full resource at mdlinx.com
Most Recently Shared on April 19, 2011 at 4:34 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation... http://bit.ly/hcz3IC #GI
Gastroenterology Article | Hepatitis B, Chronic
mdlinx.com — “The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir” View full resource at mdlinx.com
Most Recently Shared on August 3, 2011 at 12:10 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir: Alim... http://bit.ly/n77KIH #GI
Gastroenterology Article | Hepatitis B, Chronic
mdlinx.com — “Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges” View full resource at mdlinx.com
Most Recently Shared on June 1, 2011 at 5:01 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and c... http://bit.ly/kOuGdb #GI
Gastroenterology Article | Hepatitis B, Chronic
mdlinx.com — “Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection” View full resource at mdlinx.com
Most Recently Shared on June 29, 2011 at 6:58 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection: Hepatology International http://bit.ly/joM5fO #GI
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
medical_tweets
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
The Lancet
Welcome to the Lancet.com on Twitter. Keep in touch with The Lancet, the world's leading general medical journal.
Advertisement
